Amlodipine Besylate
- Product NDC
- 51655-052
- 11-digit product format
- 516550052
- Labeler code
- 51655
- Product ID
- 51655-052_d4790a90-436d-bd13-e053-2a95a90a4eb5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Amlodipine Besylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Northwind Pharmaceuticals
- Application
- ANDA203245
- Marketing category
- ANDA
- Marketing start
- 2020-06-24
- Marketing end
- 0000-00-00
- Substance
- AMLODIPINE BESYLATE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51655-052-25 | 51655005225 | 60 TABLET in 1 BOTTLE, PLASTIC (51655-052-25) | 60 tablet | 2020-06-24 | 0000-00-00 | No | No | Current |
| 51655-052-52 | 51655005252 | 30 TABLET in 1 BOTTLE, PLASTIC (51655-052-52) | 30 tablet | 2020-07-01 | 0000-00-00 | No | No | Current |